<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article50</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index_gpt.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/TTM" style="display:block; margin-bottom:10px;">TTM Original</a></li>
<h2><strong>TTM</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Targeted Temperature Management at 33°C Versus 36°C after Cardiac Arrest". The New England Journal of Medicine. 2013. 369:2197-2206. PubMed•Full text•PDF<br/>
<br/>
<h2><strong>Contents</strong></h2><br/>
<br/>
1 Clinical Question<br/>
2 Bottom Line<br/>
3 Major Points<br/>
4 Guidelines<br/>
5 Design<br/>
6 Population<br/>
  6.1 Inclusion Criteria<br/>
  6.2 Exclusion Criteria<br/>
  6.3 Baseline Characteristics<br/>
7 Interventions<br/>
8 Outcomes<br/>
  8.1 Primary Outcome<br/>
  8.2 Secondary Outcomes<br/>
9 Criticisms<br/>
10 Funding<br/>
11 Further Reading<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
<br/>
Does targeted temperature management at 33°C provide any benefit compared with a target of 36°C in unconscious survivors of out-of-hospital cardiac arrest of presumed cardiac cause?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
<br/>
Targeting a body temperature of 33°C did not reduce mortality or improve neurologic outcomes compared with a target of 36°C in unconscious patients after out-of-hospital cardiac arrest.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/>
<br/>
Hypothermia at 33°C is no more effective than 36°C in preventing death or poor neurologic function at 180 days in survivors of out-of-hospital cardiac arrest of presumed cardiac cause.<br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
<br/>
Current international resuscitation guidelines recommend therapeutic hypothermia for unconscious adult patients with return of spontaneous circulation after out-of-hospital cardiac arrest. Decisions about the target temperature should now consider the evidence from this trial.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
<br/>
- Multicenter, randomized, parallel-group, unblinded clinical trial<br/>
- N=950 unconscious adults after out-of-hospital cardiac arrest<br/>
- Targeted temperature management at 33°C (n=473)<br/>
- Targeted temperature management at 36°C (n=466)<br/>
- Setting: 36 ICUs in Europe and Australia<br/>
- Enrollment: November 2010 to January 2013<br/>
- Mean follow-up: 256 days<br/>
- Analysis: Modified intention-to-treat<br/>
- Primary outcome: All-cause mortality through the end of the trial<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
<br/>
Inclusion Criteria<br/>
<br/>
- Age ≥18 years, unconscious after out-of-hospital cardiac arrest of presumed cardiac cause<br/>
- More than 20 minutes of spontaneous circulation after resuscitation<br/>
<br/>
Exclusion Criteria<br/>
<br/>
- Interval from return of spontaneous circulation to screening &gt;240 minutes<br/>
- Unwitnessed arrest with asystole as initial rhythm, suspected intracranial hemorrhage or stroke, body temperature &lt;30°C<br/>
<br/>
Baseline Characteristics<br/>
<br/>
- Mean initial recorded body temperature: 35.2°C in the 33°C group; 35.3°C in the 36°C group<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
<br/>
- Randomization to targeted body temperature of either 33°C or 36°C<br/>
- Aim to achieve target temperature as rapidly as possible using ice-cold fluids, ice packs, intravascular or surface temperature management devices<br/>
- Mandatory sedation maintained for the 36-hour intervention period<br/>
- Temperature-controlled rewarming commenced after 28 hours<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
<br/>
Primary Outcome<br/>
<br/>
- All-cause mortality at the end of the trial: 50% in the 33°C group vs. 48% in the 36°C group (HR 1.06; 95% CI 0.89-1.28; P=0.51)<br/>
<br/>
Secondary Outcomes<br/>
<br/>
- Poor neurologic function or death at 180 days according to CPC and modified Rankin scale: 54% vs. 52% with CPC (RR 1.02; 95% CI 0.88-1.16; P=0.78); 52% vs. 52% with modified Rankin scale (RR 1.01; 95% CI 0.89-1.14; P=0.87)<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
<br/>
- Lack of blinding for ICU staff managing the patients' temperature<br/>
- Some patients in the 33°C group were rewarmed earlier than intended by protocol<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
<br/>
Funded by the Swedish Heart–Lung Foundation, Arbetsmarknadens Försäkringsaktiebolag Insurance Foundation, Swedish Research Council, Region Skåne, National Health Service, Thelma Zoega Foundation, Krapperup Foundation, Thure Carlsson Foundation, Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research, Skåne University Hospital, TrygFonden, and European Clinical Research Infrastructures Network.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
<br/>
Nielsen N, Wetterslev J, Cronberg T, et al. Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest. N Engl J Med. 2013;369(23):2197-2206. doi:10.1056/NEJMoa1310519
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
